Bone cancer info

"I had this terrible bone pain in my head, spine, ribs, and all over. Then the doctor told me he had discovered holes in my skull the size of nickels and dimes. I felt just terrible pain and needed to sleep all the time to escape it. I took pain pills and sleeping pills. It turned out - the final diagnosis offered by my newly acquired oncologist - that I had been struck by multiple myeloma," states 67-year-old clergyman Kenneth Walker of Fox Island, Washington. "On March 19, 2001 he told me the diagnosis and in June he advised that because my anemia was so severe, 'The cancer is ravaging your bone marrow - you have less than three months to live unless you undergo chemotherapy.'"

Also referred to as malignant plasmacytoma or plasma cell myeloma or myelomatosis, multiple myeloma is a disseminated neoplasm of marrow plasma cells. The disease infiltrates bone to produce osteolytic lesions throughout the skeleton (particularly in the flat bones, vertebrae, skull, pelvis, and ribs). Standard treatment is cytotoxic chemotherapy using cyclophosphamid or melphalan - both administered with prednisone to suppress plasma cell growth and control pain. The medical profession considers this disease incurable. According to a respected reference source, within three months of diagnosis 52% of patients die; within two years, 90% die. (1)

"Today, this same oncologist advises me that if I was visiting him for the first time, he would not suspect cancer had ever been present. The treatment I researched and adopted on my own saved me," affirms Reverend Walker. "At the doctor's request I have documented what he describes as 'such a fantastic result.'"

Illustrative of the "fantastic result" for Ken Walker is that no symptoms of multiple myeloma remain. He is now retired and enjoying a leisure life to the fullest. During the late summer of 2001, for example, the retired clergyman and his wife spent six weeks circumnavigating Canada's Vancouver Island in their sailboat. During the week just prior to Thanksgiving 2002, he flew to Aruba to engage in scuba diving with dive master and Oriental medicine specialist Carlos Viana, OMO, who practices holistic medicine in Aruba and throughout the Netherlands Antilles.

Reverend Ken Walker (no relation to the author) is utilizing the newest concept in nutritional supplements, an organic "metallovitamin" and amino acid produced under three patents first issued by the US Government in October 1995 to electro-biochemist and former US Navy dentist Merrill Garnett, PhD, DDS, of Islip, Long Island, New York. This metallovitamin derived from a lipoic acid and palladium complex, will be described in detail.

Breast Cancer Remission for Sarah J. Jones

"During February 2002, I discovered a lump in my left breast that seemed pretty big," says Sarah J. Jones of Denver, Colorado. "Because I could not get an evaluation appointment at the Sally Jobe Diagnostic Center in Greenwood Village, Colorado for several weeks, I researched the holistic medical literature on my own and took a number of nutritional supplements," Sarah says. "When finally I was seen at the Sally Jobe Center, their multiple Doppler ultrasound films confirmed my breast lump as potentially cancerous. The radiologist browbeat me to have a biopsy, which I refused because of what I had learned from my reading about the spread of cancer from biopsies.

"With hands on hips and challenge in her voice, the head nurse at Sally Jobe Center announced to me, 'From their star shape, I guarantee that the cells in your breast lump are cancerous.' "If that be true," I wonderedrating normal cells surrounding a core of central tumor necrosis consisting of dead cancer cells.

9. LAPd stimulates the infiltration of leukocytes for the removal of cancer cell debris.

10. LAPd has absolutely no toxic reaction -- no adverse side effects.

11. LAPd accomplishes its therapeutic benefits in both animals and humans.

12. LAPd works against cancer of many types not only as an orally administered liquid but also perhaps even more effectively as an intravenous injection.

13. LAPd reduces the incidence of cachexia with a potential for increased body weight of the frail cancer patient.

Being aware of the LAPd actions in Poly-MVA, Robert D. Milne, MD, Medical Director of the Milne Medical Center in Las Vegas, Nevada, has employed the metallovitamin complex for a family member and for the adjunctive nutritional healing of cancer in numbers of patients. He does not treat cancer but offers his patients nutritional support for their cancer. Poly-MVA is one of the more vital nutrients that Dr. Milne recommends.

"After undergoing a full oncological evaluation, my father-in-law at age 69 asked me to help him with a potentially deadly 14-cm by 2.5 cm-size Stage 3 transitional cell carcinoma of the bladder producing right-ureter obstruction," explains Dr. Milne. "Hospitalized in a critical care unit for ten days with acute respiratory distress syndrome from his adverse reaction to chemotherapy, my father-in-law was no longer a candidate for cytotoxic therapy. Upon my educating him about Poly-MVA, he undertook a therapeutic trial of this nutritional agent. With the Poly-MVA, I also recommended that he take 500 mg daily of coenzyme Q10 and 25 tablets daily of pancreatic enzymes. The treatment proved successful for him.

"His original tumor biopsy taken July 2001 was reported by the pathologist as 'invasive carcinoma Grade 2 with invasion into the muscularis propria.' Using just the nutritional program I had recommended," says Dr. Milne, "a report on the six-month followup biopsy of my father-in-law's tumor on January 11, 2002 stated, 'There is no cancer.' And his CAT scan showed, 'No evidence of the tumor in this patient's bladder.'

"I believe that the Poly-MVA adjunct for this patient was exceedingly helpful, and the work of Dr. Merrill Garnett is truly remarkable. It's different from any other therapy that has ever been done against cancer," says Dr. Robert D. Milne. "Based on my father-in-law's excellent result and the results experienced by many others, I truly believe that Poly-MVA is worth trying by any person who has cancer or wants to prevent its onset."

Resources

Further information about Merrill Garnett, PhD, DDS, and his work in the field of bio-energetics may be found on Dr. Garnett's website at www.electrogenetics.com

People wanting additional information about Poly-MVA should visit the particular website at www.polymva.com

Anyone requiring a contact list of cancer survivors who have benefited from Poly-MVA and for a second list of over 150 health professionals who provide patients with Poly-MVA, should visit the survivors' website at www.polymvasurvivors.com

Health professionals and others seeking information about how to participate in the Practitioners' Study on Poly-MVA, may acquire a complimentary practitioners' informational packet, which includes Dr. Garnett's published book, First Pulse, plus more general material about the LAPd molecule of Poly-MVA. Make your request to Emmy McAllister at Health Solutions Now!, P.O. Box 1177, Snohomish, Washington 98291; 425-334-9644; Fax 425-334-9834; Email: HealthSolutionsNow@earthlink.net

Ms. Emmy McAllister is the information agent representing the charitable organization responsible for supporting Dr. Merrill Garnett's metallochemical research, the Advanced Medicine and Research Center (AMARC), Albert Sanchez, PhD, EdS, President, 539 Telegraph Canyon Road, #281, Chula Vista, California 91910; 619-628-4751 or 619-628-4745; Fax 619-628-4749; Email: answers2cancer@hotmail. com.

Health professionals having more technical biochemical/physiological questions may telephone the inventor/ creator of Poly-MVA, Dr. Merrill Garnett, directly at his office in Islip, New York at 631-774-3821.

Persons wishing to acquire a supply of oral Poly-MVA and other nutritional substances may contact the primary commercial source in North America, AMARC Enterprises, Inc., Albert Sanchez, Jr., President; 866-Poly-MVA i.e. 866-765-9682; Email: info@polymva.com.

For further information about his multiple myeloma remission experience, contact Reverend Ken Walker, 221 Bella Vista Drive, Fox Island, Washington 98333; 253-5497676; Email: kwalk@centurytel.net

For further information about her breast cancer reduction experience, contact Sarah Jones, Cavitat Medical Tech Inc., 10691 East Bethany Drive, Suite 900, Aurora, Colorado 80014-2670; 303-755-2688.

For further information about therapy for his son Mark or other patients taking the Poly-MVA, contact Stanley R. Olsztyn, MD, 4350 East Camelback Road, Suite B-220, Phoenix, Arizona 85018; 602-8408424; Email: srolsztyn@aol.com

For further information about his experience administering Poly-MVA and the adaptation of Dr. Rudy Falk's original protocol, contact Ahmed Nasri, MD, 730 Essa Road, Barrie, Ontario, Canada L4N 9E9; Tel. 705735-2354; Email: ncim@hotmail.com.